High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas

American Journal of Surgical Pathology

Volumn 33, Issue 6, 2009, Pages 863-873

  Chen, Wei ^a   Lau, Sean K ^a   Fong, Dean ^b   Wang, Jun ^c   Wang, Endi ^d   Arber, Daniel A ^b   Weiss, Lawrence M ^a   Huang, Qin ^a,e  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e The Affiliated Sir Run Run Hospital of Nanjing Medical University   (China)

Author keywords

Differentiation; Histiocytic and dendritic cell sarcoma; Immunoglobulin receptor gene rearrangements

Indexed keywords

CD1 ANTIGEN; CD15 ANTIGEN; CD163 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RB ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD7 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; FASCIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOSIALIN; LYSOZYME; MELAN A; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN P53; PROTEIN S 100; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BOB.1; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN;

AGED; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL STRUCTURE; CHILD; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; CONTROLLED STUDY; DENDRITIC CELL SARCOMA; DNA SEQUENCE; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; GENOTYPE; HISTIOCYTE; HISTIOCYTIC SARCOMA; HUMAN; HUMAN TISSUE; IGH BCL2 FUSION GENE; IGH GENE; IGK GENE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RECEPTOR GENE; SCHOOL CHILD; VALIDATION PROCESS; ADOLESCENT; ADULT; FOLLICULAR DENDRITIC CELL SARCOMA; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CHILD; DENDRITIC CELL SARCOMA, FOLLICULAR; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; HISTIOCYTIC SARCOMA; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67549104301     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31819287b8     Document Type: Article

References (53)

1. Anderson LJ, Longnecker R. Epstein Barr virus latent membrane protein 2A exploits Notch1 to alter B cell identity in vivo. Blood. 2008. [Epub ahead of print Sep 24, 2008].
2. Arai E, Su WP, Roche PC, et al. Cutaneous histiocytic malignancy. Immunohistochemical re-examination of cases previously diagnosed as cutaneous "histiocytic lymphoma" and "malignant histiocyto-sis." J Cutan Pathol. 1993;20:115-120.
3. Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions. Blood. 1998;91:1864-1872.
4. Baker BW, Deane M, Gilleece MH, et al. Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myeloma. Leuk Lymphoma. 1994;14:291-301.
5. Bedell V, Forman SJ, Gaal K, et al. Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections. J Mol Diagn. 2007;9:589-597.
6. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucl Acids Res. 2008;36:W503-W508.
7. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol. 2004;22:55-79.
8. Chan JK, Tsang WY, Ng CS, et al. Follicular dendritic cell tumors of the oral cavity. Am J Surg Pathol. 1994;18:148-157.
9. Chang KL, Chen YY, Shibata D, et al. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
10. Cline MJ. Histiocytes and histiocytosis. Blood. 1994;84:2840-2853.
11. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007;449:473-477.
12. Copie-Bergman C, Wotherspoon AC, Norton AJ, et al. True histio-cytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol. 1998;22:1386-1392.
13. Deane M, Norton JD. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol. 1990;20:2209-2217.
14. Efremov DG, Ivanovski M, Siljanovski N, et al. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood. 1996; 87:3869-3876.
15. Egeler RM, Schmitz L, Sonneveld P, et al. Malignant histiocytosis: a reassessment of cases formerly classified as histiocytic neoplasms and review of the literature. Med Pediatr Oncol. 1995;25:1-7.
16. Feldman AL, Minniti C, Santi M, et al. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5:248-250.
17. Feldman AL, Berthold F, Arceci RJ, et al. Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 2005;6:435-437.
18. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433-5439.
19. Foreman AL, Lemercier B, Lim A, et al. VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC. Autoimmunity. 2008;41:80-86.
20. Fugmann SD, Lee AI, Shockett PE, et al. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol. 2000;18:495-527.
21. Funkhouser WK, Warnke RA. Preferential IgH V4-34 gene segment usage in particular subtypes of B-cell lymphoma detected by antibody 9G4. Hum Pathol. 1998;29:1317-1321.
22. Gong JZ, Zheng S, Chiarle R, et al. Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. Am J Pathol. 1999;155:355-363.
23. Graf I. Differentiation plasticity of hematopoietic cells. Blood. 2002; 99:3089-3101.
24. Hanson CA, Jaszcz W, Kersey JH, et al. True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis. Br J Haematol. 1989;73:187-198.
25. Hollowood K, Stamp G, Zouvani I, et al. Extranodal follicular dendritic cell sarcoma of the gastrointestinal tract. Morphologic, immunohistochemical and ultrastructural analysis of two cases. Am J Clin Pathol. 1995;103:90-97.
26. Huang Q, Chang KL, Gaal KK, et al. KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma. Am J Surg Pathol. 2004;28:693-697.
27. Huang Q, Wilczynski SP, Chang KL, et al. Composite recurrent Hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces. Am J Clin Pathol. 2006;126:222-229.
28. Isaacson PG, O'Connor NT, Spencer J, et al. Malignant histiocy-tosis of the intestine: a T-cell lymphoma. Lancet. 1985;2:688-691.
29. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood. 1998;91:2433-2442.
30. Jaffe ES. Malignant histiocytosis and true histiocytic lymphomas. In: Jaffe ES, ed. Surgical Pathology of the Lymph Nodes and Related Organs. Philadelphia: WB Saunders Co; 1985:381-411.
31. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158:235-246.
32. Luthra R, McBride JA, Cabanillas F, et al. Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma. Am J Pathol. 1998;153:63-68.
33. Malone CS, Patrone L, Buchanan KL, et al. An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression. J Immunol. 2000;164:2550-2556.
34. Marasca R, Vaccari P, Luppi M, et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol. 2001;159:253-261.
35. Milchgrub S, Kamel OW, Wiley E, et al. Malignant histiocytic neoplasms of the small intestine. Am J Surg Pathol. 1992;16:11-20.
36. Morris MW, Davey FR. Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas. Am J Clin Pathol. 1975;63:403-414.
37. Pfisterer P, Konig H, Hess J, et al. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol. 1996;16:6160-6168.
38. Ralfkiaer E, Delsol G, O'Connor NT, et al. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol. 1990;160:9-17.
39. Rettig MB, Vescio RA, Cao J, et al. VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood. 1996;87:2846-2852.
40. Segal GH, Jorgensen T, Scott M, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas. Hum Pathol. 1994;25:1276-1282.
41. Spellerberg M, Chapman C, Hamblin T, et al. Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus. Ann N Y Acad Sci. 1995;764:427-432.
42. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-858.
43. Grogan TM, Pileri SA, Chan JKC, et al. Histiocytic and dendritic cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:353-367.
44. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003;101: 4952-4957.
45. Van dV, van Oostveen JW, Stel HV, et al. Phenotypic and genotypic analysis of large-cell lymphomas, formerly classified as true histiocytic lymphoma: identification of an unusual group of tumors. Leuk Res. 1990;14:337-346.
46. Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18:693-704.
47. Walsh SH, Thorselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood. 2003;101:4047-4054.
48. Weiss LM, Trela MJ, Cleary ML, et al. Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. Am J Pathol. 1985;121:369-373.
49. Weiss LM, Berry GJ, Dorfman RF, et al. Spindle cell neoplasms of lymph nodes of probable reticulum cell lineage. True reticulum cell sarcoma? Am J Surg Pathol. 1990;14:405-414.
50. Weiss LM, Grogan TM, Muller-Hermelink HK, et al. Histiocytic and dendritic cell neoplasms. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:274-289.
51. Xie H, Orkin SH. Immunology: changed destiny. Nature. 2007;449: 410-411.
52. Xie H, Ye M, Feng R, et al. Step wise reprogramming of B cells into macrophages. Cell. 2004;117:663-676.
53. Yamada M, Wasserman R, Reichard BA, et al. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med. 1991;173:395-407.